Literature DB >> 30445575

Quality of life assessment using patient-reported outcome (PRO) measures: still a Cinderella outcome?

L J Fallowfield1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30445575     DOI： 10.1093/annonc/mdy481

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  5 in total

1.  Health-Related Quality of Life in MONARCH 2: Abemaciclib plus Fulvestrant in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer After Endocrine Therapy.

Authors:  Peter A Kaufman; Masakazu Toi; Patrick Neven; Joohyuk Sohn; Eva-Maria Grischke; Valerie Andre; Clemens Stoffregen; Sarah Shekarriz; Gregory L Price; Gebra Cuyun Carter; George W Sledge
Journal:  Oncologist       Date:  2019-10-24

2.  Quality of Life in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy-The Randomized NORDIC9-Study.

Authors:  Gabor Liposits; Henrik Rode Eshøj; Sören Möller; Stine Brændegaard Winther; Halla Skuladottir; Jesper Ryg; Eva Hofsli; Carl-Henrik Shah; Laurids Østergaard Poulsen; Åke Berglund; Camilla Qvortrup; Pia Österlund; Bengt Glimelius; Halfdan Sorbye; Per Pfeiffer
Journal:  Cancers (Basel)       Date:  2021-05-26       Impact factor: 6.639

Review 3.  Digital health for optimal supportive care in oncology: benefits, limits, and future perspectives.

Authors:  M Aapro; P Bossi; A Dasari; L Fallowfield; P Gascón; M Geller; K Jordan; J Kim; K Martin; S Porzig
Journal:  Support Care Cancer       Date:  2020-06-12       Impact factor: 3.603

4.  Health-Related Quality of Life in MONARCH 2: Abemaciclib plus Fulvestrant in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer After Endocrine Therapy.

Authors:  Peter A Kaufman; Masakazu Toi; Patrick Neven; Joohyuk Sohn; Eva-Maria Grischke; Valerie Andre; Clemens Stoffregen; Sarah Shekarriz; Gregory L Price; Gebra Cuyun Carter; George W Sledge
Journal:  Oncologist       Date:  2019-10-24

5.  Health-Related Quality of Life in MONARCH 3: Abemaciclib plus an Aromatase Inhibitor as Initial Therapy in HR+, HER2- Advanced Breast Cancer.

Authors:  Matthew P Goetz; Miguel Martin; Eriko Tokunaga; In Hae Park; Jens Huober; Masakazu Toi; Clemens Stoffregen; Sarah Shekarriz; Valerie Andre; M Corona Gainford; Gregory L Price; Stephen Johnston
Journal:  Oncologist       Date:  2020-06-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.